Why pursue a career in the pharma industry?
From a young age, I was drawn to fields that combined innovation with a clear impact on people’s lives. During my studies, I became fascinated by how science and engineering could be applied to improve healthcare outcomes. The pharmaceutical industry, with its potential to develop lifesaving technologies and medicines, felt like the perfect match for my skills and interests. This motivation has only deepened over time as I’ve witnessed the critical role the industry plays in global health.
What do you do in your current role?
I currently serve as the Chairman and CEO of Biogenera, an Italian biotech company that develops precision medicine technology based on peptide nucleic acids technology. Our first candidate drug is set to enter clinical trial phase 1 later this year. I lead the company’s strategic vision, drive innovation in drug development, and oversee operations to ensure we are making meaningful advancements in patient care. It is an incredible privilege to be at the forefront of such transformative work.
What do you enjoy most about your work?
I enjoy most the dynamic and challenging reality of a biotech startup like Biogenera. Every day presents opportunities to solve complex problems, push the boundaries of innovation, and navigate uncharted territories in drug development. Knowing that our first drug, aimed at pediatric patients, is entering clinical trial phase 1 this year is particularly meaningful to me. The ability to contribute to treatments for children, which is a cause close to my heart, makes this work deeply fulfilling.
Tell us about a project you’re proud of.
One of the most rewarding projects I’ve worked on was the launch of a division dedicated to ATMPs. At the time, we were at the forefront, pioneering what has now become a competitive and rapidly growing market. Leading this initiative required vision, collaboration, and adaptability, and I’m proud of how we anticipated industry trends and set the stage for innovative advancements in this field.
What do you see next for your area?
The pharmaceutical industry is moving toward increased automation, digitalization, and sustainability. For biotech startups like Biogenera, the next big advances will come from leveraging artificial intelligence to accelerate drug discovery and development and from fostering strategic partnerships to bring innovations to market faster. These advancements will play a crucial role in addressing unmet medical needs and improving patient outcomes across various therapeutic areas.
What advice would you give Emerging Leaders?
Stay curious and never stop learning. The pharmaceutical industry is constantly evolving, and Emerging Leaders need to stay ahead by understanding both the technical and regulatory landscapes. I would also emphasize the importance of collaboration and building strong professional networks. Lastly, always keep the patient at the center of what you do. This perspective will guide your decisions and inspire your work.
What do you gain from volunteering with ISPE?
My work with ISPE has been incredibly rewarding, particularly as the chair of the SPP CoP. It’s a privilege to collaborate with such talented professionals and contribute to advancing knowledge in this critical area. ISPE has provided me with unparalleled opportunities for professional development and networking. What I enjoy most, though, is the sense of community and shared purpose among members.
Join a Communities of Practice
Are you an ISPE Member looking for a better way to connect with your colleagues from around the globe? Or are you a Member seeking information on new trends, issues or concerns affecting your profession and your day-to-day work life? Join an ISPE Community of Practice (CoP). CoPs are groups of ISPE Members with a common interest and similar job functions who collaborate on topic-specific discussions using the ISPE networking forum, ISPE Engage.
